Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - Related Studies

Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

This study is ongoing, but not recruiting participants.

Study NCT00390403. Last updated on November 8, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Central Nervous System Neoplasms
		Glioblastoma
		Nervous System Neoplasms

2	More general conditions related to this trial
		Astrocytoma
		Glioma
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neoplasms, Neuroepithelial
		Nervous System Diseases
		Neuroectodermal Tumors

3	Interventions listed in this trial
		R-(-)-gossypol acetic acid
		temozolomide
		adjuvant therapy
		gene expression analysis
		laboratory biomarker analysis
		mutation analysis
		pharmacological study
		protein expression analysis
		radiation therapy

4	Additional drug interventions recognized in this trial
		Gossypol
		Gossypol acetic acid

5	More general drug interventions related to this trial
		Alkylating Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Phytogenic
		Antispermatogenic Agents
		Contraceptive Agents
		Contraceptive Agents, Female
		Contraceptive Agents, Male
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Spermatocidal Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		National Cancer Institute (NCI)